Cell-Free Methylated

liquid profiling mPTGER4 mSHOX2 methylation plasma

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
21 Jun 2023
Historique:
received: 03 05 2023
revised: 13 06 2023
accepted: 15 06 2023
medline: 14 7 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: epublish

Résumé

Notwithstanding some improvement in the earlier detection of patients with lung cancer, most of them still present with a late-stage disease at the time of diagnosis. Next to the most frequently utilized factors affecting the prognosis of lung cancer patients (stage, performance, and age), the recent application of biomarkers obtained by liquid profiling has gained more acceptance. In our study, we aimed to answer these questions: (i) Is the quantification of free-circulating methylated

Identifiants

pubmed: 37443525
pii: diagnostics13132131
doi: 10.3390/diagnostics13132131
pmc: PMC10340633
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Thorac Oncol. 2011 Oct;6(10):1632-8
pubmed: 21694641
Oncogene. 2019 May;38(18):3387-3401
pubmed: 30643192
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Transl Oncol. 2022 Jan;15(1):101279
pubmed: 34800919
Int J Mol Sci. 2022 Aug 12;23(16):
pubmed: 36012272
Nat Med. 1996 Sep;2(9):1033-5
pubmed: 8782463
Clin Epigenetics. 2022 Dec 2;14(1):163
pubmed: 36461127
Oncologist. 2021 Oct;26(10):e1812-e1821
pubmed: 34216176
Cancers (Basel). 2019 Nov 06;11(11):
pubmed: 31698791
Clin Chem. 2003 Jun;49(6 Pt 1):1028-9
pubmed: 12766024
J Exp Clin Cancer Res. 2021 Apr 26;40(1):140
pubmed: 33902698
J Thorac Oncol. 2017 Jan;12(1):77-84
pubmed: 27544059
Lung Cancer. 2013 Sep;81(3):397-403
pubmed: 23806794
Oncology. 1989;46(5):318-22
pubmed: 2779946
Clin Chem Lab Med. 2014 Jun;52(6):899-909
pubmed: 24406287
C R Seances Soc Biol Fil. 1948 Feb;142(3-4):241-3
pubmed: 18875018
Mol Cancer. 2022 Mar 21;21(1):81
pubmed: 35307037
Int Rev Cytol. 1977;51:1-48
pubmed: 338535
Eur J Cancer Clin Oncol. 1987 Jun;23(6):707-12
pubmed: 3653190
Int J Mol Sci. 2021 Jan 09;22(2):
pubmed: 33435440
Clin Chim Acta. 2017 Jun;469:94-98
pubmed: 28373054
Ann Oncol. 2015 Sep;26(9):1994-1999
pubmed: 26113646
PLoS One. 2015 Feb 12;10(2):e0118195
pubmed: 25675432
Clin Epigenetics. 2015 Nov 05;7:119
pubmed: 26550041
Mol Diagn Ther. 2017 Oct;21(5):563-570
pubmed: 28631163
Acta Cytol. 2019;63(6):489-496
pubmed: 30566947

Auteurs

Michael Fleischhacker (M)

Klinik für Innere Medizin-Schwerpunkt Pneumologie und Schlafmedizin, DRK Kliniken Berlin/Mitte, 13359 Berlin, Germany.

Erkan Arslan (E)

Lungenarztpraxis Berlin-Reinickendorf, 13403 Berlin, Germany.

Dana Reinicke (D)

Department für Innere Medizin, Universitätsklinikum Halle/Saale, 06120 Halle (Saale), Germany.

Stefan Eisenmann (S)

Department für Innere Medizin, Universitätsklinikum Halle/Saale, 06120 Halle (Saale), Germany.

Gerit Theil (G)

Department für Innere Medizin, Universitätsklinikum Halle/Saale, 06120 Halle (Saale), Germany.

Jens Kollmeier (J)

Lungenklinik Heckeshorn, Helios Klinikum Emil von Behring, 14165 Berlin, Germany.

Christoph Schäper (C)

Klinik und Poliklinik für Innere Medizin B, Universitätsmedizin Greifswald, 17475 Greifswald, Germany.

Christian Grah (C)

Gemeinschaftskrankenhaus Havelhöhe, Pneumologie und Lungenkrebszentrum, 14089 Berlin, Germany.

Frank Klawonn (F)

Department of Computer Science, Ostfalia University, 38302 Wolfenbüttel, Germany.
Biostatistics, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany.

Stefan Holdenrieder (S)

Munich Biomarker Research Center, Institute of Laboratory Medicine, German Heart Centre, Technical University Munich, Lazarettstraße 36, 80636 Munich, Germany.

Bernd Schmidt (B)

Klinik für Innere Medizin-Schwerpunkt Pneumologie und Schlafmedizin, DRK Kliniken Berlin/Mitte, 13359 Berlin, Germany.

Classifications MeSH